Welcome to the Brilliant Together Podcast series. This episode showcases the major milestones of the Brintellix strategy evolution and the key to unlock successful sales. To reach the full potential of Brintellix, we need to go after the largest opportunities for growth. We do that by understanding the buying process and decision-making drivers of the three doctor types most likely to prescribe Brintellix to patients with depression. If we strategically focus on the patients whose symptoms meet those of Detached Debbie, we offer physicians a positive experience and accelerate the journey for low prescribers to become high prescribers.
Key Takeaways:
[5:35] Meet the three doctor types who treat patients with depression, Dr. Mood, Dr. Function, and Dr. Progressive.
[11:55] What type of patient offers the largest opportunity for growth?
[14:43] Low prescribers will have positive experiences prescribing Brintellix to the Detached Debbie targeted patient segment.
[19:20] How Brintellix increases a patient's chances of remission and works within a physician's engrained treatment habit.
[23:19] Move the buying process forward by reframing the language to reflect progress and initiate Brintellix.
Resources:
